← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Synergy CHC Corp. (SNYR) 10-Year Financial Performance & Capital Metrics

SNYR • • Industrial / General
HealthcareMedical DistributionConsumer Healthcare ProductsOTC Healthcare Brands
AboutSynergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.Show more
  • Revenue $35M -18.6%
  • EBITDA $6M -45.3%
  • Net Income $2M -66.5%
  • EPS (Diluted) 0.28 +297.2%
  • Gross Margin 67.87% -9.5%
  • EBITDA Margin 17.04% -32.8%
  • Operating Margin 16.65% -34.1%
  • Net Margin 6.1% -58.8%
  • ROE -
  • ROIC 88.11%
  • Debt/Equity -
  • Interest Coverage 1.41 -44.6%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Share count reduced 91.5% through buybacks
  • ✓Efficient asset utilization: 2.1x turnover

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 16 (bottom 16%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y0.59%
3Y-4.68%
TTM-8.45%

Profit (Net Income) CAGR

10Y-
5Y-
3Y14.62%
TTM-44.03%

EPS CAGR

10Y-
5Y-
3Y161.27%
TTM-0.78%

ROCE

10Y Avg-9.54%
5Y Avg-27.36%
3Y Avg88.11%
Latest88.11%

Peer Comparison

OTC Healthcare Brands
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
PBHPrestige Consumer Healthcare Inc.3.15B65.6115.291.1%18.08%11%7.71%0.57
SNYRSynergy CHC Corp.20.48M1.826.50-18.57%7.46%

Profit & Loss

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2022Dec 2023Dec 2024
Sales/Revenue+9.16K13.46M34.84M35.6M33.82M29.36M40.23M38.41M42.78M34.83M
Revenue Growth %-1468.36%1.59%0.02%-0.05%-0.13%0.37%-0.05%0.11%-0.19%
Cost of Goods Sold+5.62K5.31M10.21M9.82M12.47M9.14M14.68M25.45M10.7M11.19M
COGS % of Revenue0.61%0.39%0.29%0.28%0.37%0.31%0.36%0.66%0.25%0.32%
Gross Profit+3.54K8.15M24.64M25.78M21.35M20.22M25.55M12.96M32.08M23.64M
Gross Margin %0.39%0.61%0.71%0.72%0.63%0.69%0.64%0.34%0.75%0.68%
Gross Profit Growth %-2299.46%2.02%0.05%-0.17%-0.05%0.26%-0.49%1.48%-0.26%
Operating Expenses+961.64K7.66M19.52M23.96M25.34M28.18M22.46M37.92M21.27M17.84M
OpEx % of Revenue105.01%0.57%0.56%0.67%0.75%0.96%0.56%0.99%0.5%0.51%
Selling, General & Admin961.64K7.05M18.35M22.46M23.52M16.97M22.46M37.92M21.24M17.71M
SG&A % of Revenue105.01%0.52%0.53%0.63%0.7%0.58%0.56%0.99%0.5%0.51%
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses0608K1.17M212.76K27.79K11.21M0033.33K133.33K
Operating Income+-958.09K486.02K2.93M1.82M-4.92M-7.96M3.09M-24.97M10.81M5.8M
Operating Margin %-104.62%0.04%0.08%0.05%-0.15%-0.27%0.08%-0.65%0.25%0.17%
Operating Income Growth %-42.98%1.51%5.04%-0.38%-3.7%-0.62%1.39%-9.09%1.43%-0.46%
EBITDA+-109.04K1.09M4.1M3.32M-3.1M-6.74M3.19M-24.63M10.84M5.93M
EBITDA Margin %-11.91%0.08%0.12%0.09%-0.09%-0.23%0.08%-0.64%0.25%0.17%
EBITDA Growth %-6.11%11.03%2.75%-0.19%-1.93%-1.18%1.47%-8.73%1.44%-0.45%
D&A (Non-Cash Add-back)849.05K608K1.17M1.49M1.82M1.21M100.27K340K33.33K133.33K
EBIT-958.09K-6.19M3.34M1.86M-5.28M-8.09M2.71M-26.15M10.81M6.33M
Net Interest Income+-2K-957.28K-3.4M-1.27M-1.35M-1.11M-1.3M-6.45M-4.23M-4.1M
Interest Income01.46K5.11K202354141045691.62K1.52K
Interest Expense2K958.74K1.57M1.04M1.13M1.11M1.3M6.45M4.24M4.11M
Other Income/Expense-2K-7.63M-4.96M-1.01M-1.49M-1.12M-1.67M-7.63M-4.23M-3.57M
Pretax Income+-960.09K-7.15M148.2K815.58K-6.41M-9.08M1.41M-32.6M6.57M2.23M
Pretax Margin %-104.84%-0.53%0%0.02%-0.19%-0.31%0.04%-0.85%0.15%0.06%
Income Tax+0389.94K944.36K316.01K-247.69K131.54K032.17K234.98K102.08K
Effective Tax Rate %1%1.05%-5.37%0.61%0.96%1.01%1%1%0.96%0.95%
Net Income+-960.09K-7.54M-796.16K499.57K-6.16M-9.21M1.41M-32.63M6.34M2.12M
Net Margin %-104.84%-0.56%-0.02%0.01%-0.18%-0.31%0.04%-0.85%0.15%0.06%
Net Income Growth %-40.38%-6.85%0.89%1.63%-13.33%-0.49%1.15%-24.12%1.19%-0.66%
Net Income (Continuing)-960.09K-7.54M-796.16K499.57K-6.16M-9.21M1.41M-32.63M6.34M2.12M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)+-0.02-0.11-0.010.01-0.07-0.100.02-0.360.070.28
EPS Growth %--6.33%0.91%---0.46%1.16%-23.93%1.2%2.97%
EPS (Basic)-0.02-0.11-0.010.01-0.07-0.100.02-0.360.860.28
Diluted Shares Outstanding63.99M68.85M81.65M89.24M89.86M89.88M89.89M89.89M89.89M7.63M
Basic Shares Outstanding63.99M68.85M81.65M89.24M89.86M89.88M89.89M89.89M7.37M7.59M
Dividend Payout Ratio----------

Balance Sheet

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2022Dec 2023Dec 2024
Total Current Assets+55.38K9.34M7.26M10.41M8.94M5.05M12.59M18.54M11.82M16.06M
Cash & Short-Term Investments3383.64M2.52M1.96M459.74K1.22M1.67M1.93M632.53K687.92K
Cash Only3383.64M2.52M1.96M459.74K1.22M1.67M1.93M632.53K687.92K
Short-Term Investments0000000000
Accounts Receivable2.9K3.98M2.2M4.33M4.84M1.68M6.22M7.91M6.57M11.7M
Days Sales Outstanding115.5107.952344.4452.2820.8356.4275.1456.03122.55
Inventory26.06K686.65K1.1M2.84M2.67M1.86M3.83M7.97M3.73M1.72M
Days Inventory Outstanding1.69K47.2239.44105.6778.1374.3495.2114.26127.1455.99
Other Current Assets10K607.09K100K139.07K136.18K100K874.92K739.77K100K100K
Total Non-Current Assets+017.8M13.2M13.62M11.07M143.53K00416.67K283.33K
Property, Plant & Equipment012.02K257.39K293.2K269.77K135.9K0000
Fixed Asset Turnover-1119.78x135.36x121.40x125.38x216.03x----
Goodwill011.5M7.79M7.79M7.79M00000
Intangible Assets05.92M5.15M5.53M3.01M7.64K00416.67K283.33K
Long-Term Investments0000000000
Other Non-Current Assets0378.85K00000000
Total Assets+55.38K27.14M20.46M24.03M20.01M5.19M12.59M18.54M12.24M16.34M
Asset Turnover0.17x0.50x1.70x1.48x1.69x5.66x3.20x2.07x3.50x2.13x
Asset Growth %16.14%489.09%-0.25%0.17%-0.17%-0.74%1.42%0.47%-0.34%0.34%
Total Current Liabilities+181.04K15.5M12.21M7.14M10.41M10.15M14.74M30.26M14.02M17.18M
Accounts Payable0411.03K401.59K106.39K76.62K26.21K21.72K19.6M00
Days Payables Outstanding-28.2614.363.962.241.050.54281.01--
Short-Term Debt106.4K3.78M6.64M2.49M2.14M5.47M7.52M1.03M2.09M11.73M
Deferred Revenue (Current)-15.86K1000K36K3.06K49.71K7.89K121.8K014.2K24.25K
Other Current Liabilities-4.99K6.69M1.83M94.96K850.63K07.08M9.64M7.56K0
Current Ratio0.31x0.60x0.60x1.46x0.86x0.50x0.85x0.61x0.84x0.93x
Quick Ratio0.16x0.56x0.50x1.06x0.60x0.31x0.59x0.35x0.58x0.83x
Cash Conversion Cycle-126.948.08146.15128.1794.12151.08-91.61--
Total Non-Current Liabilities+06.22M1.14M7.46M5.63M246.92K1.53M21.8M25.52M15.79M
Long-Term Debt05.72M830.25K7.46M5.63M246.92K1.23M21.8M25.52M15.79M
Capital Lease Obligations0000000000
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities0258.9K313.75K000300.77K000
Total Liabilities181.04K21.72M13.35M14.6M16.04M10.39M16.27M52.06M39.55M32.97M
Total Debt+106.4K9.87M7.47M9.95M7.77M5.71M8.75M22.83M27.62M27.52M
Net Debt106.06K6.23M4.95M8M7.31M4.49M7.08M20.9M26.99M26.83M
Debt / Equity-1.82x1.05x1.05x1.96x-----
Debt / EBITDA-9.02x1.82x3.00x--2.75x-2.55x4.64x
Net Debt / EBITDA-5.69x1.21x2.41x--2.22x-2.49x4.52x
Interest Coverage-479.53x0.51x1.87x1.75x-4.34x-7.16x2.38x-3.87x2.55x1.41x
Total Equity+-125.67K5.42M7.11M9.43M3.97M-5.2M-3.68M-33.52M-27.31M-16.63M
Equity Growth %-8.8%44.13%0.31%0.33%-0.58%-2.31%0.29%-8.1%0.19%0.39%
Book Value per Share-0.000.080.090.110.04-0.06-0.04-0.37-0.30-2.18
Total Shareholders' Equity-125.67K5.42M7.11M9.43M3.97M-5.2M-3.68M-33.52M-27.31M-16.63M
Common Stock6218178888998998998998997687
Retained Earnings-1.03M-8.57M-9.37M-8.87M-15.03M-24.23M-22.82M-52.69M-46.22M-44.1M
Treasury Stock00000000-127.5K-127.5K
Accumulated OCI40K-6.17K16.02K-77.99K179.12K11.36K-9.45K22.39K-102.47K-47.78K
Minority Interest0000000000

Cash Flow

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2022Dec 2023Dec 2024
Cash from Operations+-489.18K-644.32K6.04M-831.07K1.3M2.95M-1.59M-8.43M421.73K-4.8M
Operating CF Margin %-53.42%-0.05%0.17%-0.02%0.04%0.1%-0.04%-0.22%0.01%-0.14%
Operating CF Growth %-29.99%-0.32%10.37%-1.14%2.57%1.26%-1.54%-4.31%1.05%-12.39%
Net Income-960.09K-7.54M-796.16K499.57K-6.16M-9.21M1.41M-32.63M6.34M2.12M
Depreciation & Amortization0608K1.17M1.49M1.82M1.21M100.27K340K33.33K133.33K
Stock-Based Compensation322.25K551.71K2.2M1.46M441K201.16K0000
Deferred Taxes05.75M4.89M72.6K2.28M9.98M0000
Other Non-Cash Items109.04K1.03M-1.16M296.95K351.72K453.11K1.34M17.26M-4.33M-190.29K
Working Capital Changes39.63K-1.05M-266.53K-4.65M2.57M308.45K-4.44M6.6M-1.62M-6.87M
Change in Receivables-2.9K-1.32M1.73M-2.09M-193.69K2.75M-4.38M1.42M1.34M-4.62M
Change in Inventory-26.06K-19.63K-547.29K-1.45M-884.14K552.16K-2.13M-7.46M3.99M1.88M
Change in Payables0484.14K-1.49M-1.08M3.6M-3.73M2.71M2.86M-6.49M-2.81M
Cash from Investing+0-4.4M-2.35M-1.95M-198.01K00000
Capital Expenditures0-7.83K-302.23K-1.91M-198.01K00000
CapEx % of Revenue-0%0.01%0.05%0.01%-0%0%--
Acquisitions----------
Investments----------
Other Investing0-607.08K-2.04M-32.87K-6900000
Cash from Financing+486.28K8.68M-4.83M2.31M-2.86M-2.05M1.95M8.96M-2.09M4.8M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0-1.17M00000000
Share Repurchases----------
Other Financing-16.08K-517.3K0-452.87K0005000328K
Net Change in Cash----------
Free Cash Flow+-489.18K-652.15K5.74M-2.75M1.11M2.95M-1.59M-8.43M421.73K-4.8M
FCF Margin %-53.42%-0.05%0.16%-0.08%0.03%0.1%-0.04%-0.22%0.01%-0.14%
FCF Growth %-29.99%-0.33%9.8%-1.48%1.4%1.66%-1.54%-4.31%1.05%-12.39%
FCF per Share-0.01-0.010.07-0.030.010.03-0.02-0.090.00-0.63
FCF Conversion (FCF/Net Income)0.51x0.09x-7.58x-1.66x-0.21x-0.32x-1.13x0.26x0.07x-2.26x
Interest Paid0806.74K0842.25K1.25M939.71K004.17M3.91M
Taxes Paid012.69K01.19M224.11K38.92K0000

Key Ratios

Metric2014201520162017201820192020202220232024
Return on Equity (ROE)--284.72%-12.71%6.04%-91.92%-----
Return on Invested Capital (ROIC)-6.27%18.56%9.27%-25.69%-112.93%172.51%--88.11%
Gross Margin38.68%60.55%70.71%72.42%63.12%68.87%63.51%33.73%74.99%67.87%
Net Margin-10483.64%-56.01%-2.29%1.4%-18.21%-31.36%3.51%-84.95%14.82%6.1%
Debt / Equity-1.82x1.05x1.05x1.96x-----
Interest Coverage-479.53x0.51x1.87x1.75x-4.34x-7.16x2.38x-3.87x2.55x1.41x
FCF Conversion0.51x0.09x-7.58x-1.66x-0.21x-0.32x-1.13x0.26x0.07x-2.26x
Revenue Growth-146835.76%158.91%2.17%-4.98%-13.21%37.02%-4.51%11.37%-18.57%

Revenue by Segment

201520162017201820192024
Retail----18.97M26.47M
Retail Growth-----39.52%
Online----10.38M-
Online Growth------

Revenue by Geography

201520162017201820192024
UNITED STATES-----30.83M
UNITED STATES Growth------
United States13.13M32.01M3.29M-27.3M-
United States Growth-143.80%-89.71%---
Foreign Countries326.62K2.83M2.67M2.09M2.06M-
Foreign Countries Growth-766.55%-5.55%-21.70%-1.47%-
U.S---31.73M--
U.S Growth------

Frequently Asked Questions

Valuation & Price

Synergy CHC Corp. (SNYR) has a price-to-earnings (P/E) ratio of 6.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Synergy CHC Corp. (SNYR) reported $34.6M in revenue for fiscal year 2024.

Synergy CHC Corp. (SNYR) saw revenue decline by 18.6% over the past year.

Yes, Synergy CHC Corp. (SNYR) is profitable, generating $2.6M in net income for fiscal year 2024 (6.1% net margin).

Dividend & Returns

Synergy CHC Corp. (SNYR) had negative free cash flow of $6.6M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.